Search hospitals > Iowa > Des Moines
Mercy Medical Center - Des Moines
Claim this profileDes Moines, Iowa 50314
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
388 reported clinical trials
6 medical researchers
Summary
Mercy Medical Center - Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Adenocarcinoma and other specialties. Mercy Medical Center - Des Moines is involved with conducting 388 clinical trials across 525 conditions. There are 6 research doctors associated with this hospital, such as Richard L. Deming, Robert Hoyt, MD, Mehmet S. Copur, and David McAllister, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Robert Hoyt, MDIowa Heart Center5 years of reported clinical research
Studies Atrial Fibrillation
Studies Stroke
3 reported clinical trials
4 drugs studied
Mehmet S. CopurBethesda North Hospital12 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
2 reported clinical trials
8 drugs studied
David McAllister, MDMercy Medical Center4 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
2 reported clinical trials
3 drugs studied
Clinical Trials running at Mercy Medical Center - Des Moines
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Prostate Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Pancreatic Cancer
Colorectal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Medical Center - Des Moines?
Mercy Medical Center - Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Adenocarcinoma and other specialties. Mercy Medical Center - Des Moines is involved with conducting 388 clinical trials across 525 conditions. There are 6 research doctors associated with this hospital, such as Richard L. Deming, Robert Hoyt, MD, Mehmet S. Copur, and David McAllister, MD.
Where is Mercy Medical Center - Des Moines located?
MercyOne Des Moines Medical Center is located at 1111 6th Ave, Des Moines, IA 50314.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance and Insurance Information for Mercy Medical Center - Des Moines**
- **Mercy Health Financial Assistance Policy**: Offers financial aid to eligible patients based on income and financial resources. Information and applications are available on their website.
- **MercyOne Financial Assistance Program**: Provides financial assistance for medical bills to eligible uninsured or underinsured patients. Application and policy details are on their website.
- **MercyOne Billing & Finances**: For billing and financial inquiries, contact MercyOne at the following numbers: Clinic - 888-515-7155, Hospital - 734-343-3065, Iowa Heart - 515-633-3600, Lab - 844-405-9080. Financial counselors are available to discuss individual needs and payment arrangements.
- **MercyOne Insurance**: At registration, provide your insurance information. MercyOne will file your claim and, if possible, inform you of the approximate amount owed and arrange for payment.
- **MercyOne Discounted Charges**: Hospital patients without insurance who meet income guidelines may receive a discount off total billed charges. An application is required.
What insurance does Mercy Medical Center - Des Moines accept?
Mercy Medical Center - Des Moines accepts a broad spectrum of insurance plans, including Medicare, Medicaid, and commercial carriers like Aetna, Humana, United Healthcare, and Wellmark (BCBS). Patients are encouraged to confirm coverage and any restrictions with their insurance provider prior to scheduling visits. Note that non-participating insurance plans may lead to the patient being responsible for total billed charges.
What awards or recognition has Mercy Medical Center - Des Moines received?
Mercy Medical Center - Des Moines is an accredited cancer center by the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), highlighting its quality cancer care. It has been named a Best Regional Hospital for Des Moines and central Iowa by U.S. News & World Report. Additionally, it has earned the Blue Distinction Center Plus (+) designation for cardiac care from Blue Cross Blue Shield.